Avalglucosidase alfa improves motor and respiratory function in late-onset Pompe disease: A COMET win-ratio analysis

被引：0
|
作者：
Diaz-Manera, Jordi [1 ]
Dimachkie, Mazen M. [2 ]
Ishak, Jack [3 ]
Caro, Jaime [4 ]
Hamed, Alaa [5 ]
Franca, Lionel Riou [6 ]
Thibault, Nathan [5 ]
Shukla, Pragya [3 ]
Berger, Kenneth I. [7 ]
Boentert, Matthias [8 ]
机构：
[1] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Ctr Life, Newcastle Upon Tyne, England
[2] Univ Kansas, Dept Neurol, Med Ctr, Kansas City, KS USA
[3] Evidera, Montreal, PQ, Canada
[4] Evidera, Waltham, MA USA
[5] Sanofi, Cambridge, MA USA
[6] Sanofi, Paris, France
[7] New York Univ, Div Pulm Crit Care & Sleep Med, Grossman Sch Med, New York, NY USA
[8] Munster Univ Hosp, Dept Neurol, Munster, Germany
来源：
MOLECULAR GENETICS AND METABOLISM | 2023年 / 138卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2022.107076
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
93
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [21] The avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients: Efficacy and safety results after 97 weeks
    Kishnani, Priya
    Diaz-Manera, Jordi
    Kushlaf, Hani
    Ladha, Shafeeq
    Mozaffar, Tahseen
    Straub, Volker
    Toscano, Antonio
    van der Ploeg, Ans T.
    Berger, Kenneth I.
    Clemens, Paula R.
    Chien, Yin-Hsiu
    Day, John W.
    Illarioshkin, Sergey
    Roberts, Mark
    Attarian, Shahram
    Carvalho, Gerson
    Choi, Young-Chul
    Erdem-Ozdamar, Sevim
    Goker-Alpan, Ozlem
    Kostera-Pruszczyk, Anna
    Haack, Kristina An
    Thibault, Nathan
    Zhou, Tianyue
    Dimachkie, Mazen M.
    Schoser, Benedikt
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S66 - S67
  • [22] Dynamic respiratory muscle function in late-onset Pompe disease
    Barbara K. Smith
    Shannon Allen
    Samantha Mays
    A. Daniel Martin
    Barry J. Byrne
    Scientific Reports, 9
  • [23] Dynamic respiratory muscle function in late-onset Pompe disease
    Smith, Barbara K.
    Allen, Shannon
    Mays, Samantha
    Martin, A. Daniel
    Byrne, Barry J.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [24] Pompe Registry: Real-world experience of patients with late-onset Pompe disease who switched therapy from alglucosidase alfa to avalglucosidase alfa
    Schoser, B.
    Toscano, A.
    Foster, M.
    Sparks, S.
    Kishnani, P.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [25] Mechanism-guided analysis of avalglucosidase alfa efficacy on key biomarkers and clinical endpoints in late-onset Pompe disease patients
    Kaddi, Chanchala
    Tao, Mengdi
    Bergeler, Silke
    Leiser, Randolph
    Walker, Mike
    Geerts, Hugo
    George, Kelly
    Wilson, Catherine
    Ortemann-Renon, Catherine
    Zaher, Atef
    Zaph, Susana
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 70 - 70
  • [26] Respiratory and Motor Phenotypes and Correlations with Diaphragm Function in Patients with Late-Onset Pompe Disease (LOPD)
    Cirino Nogueira, Andrea Da Nobrega
    Marinho, Liegina Silveira
    Vasconcelos, Renata Dos Santos
    Montenegro Ponte, Suzy Maria
    Vega Canjura Sousa, Nancy Delma Silva
    Ferreira, Juliete Vaz
    Bezerra, Patricia Carvalho
    Sousa, Miguel Angelo Nobre E.
    Holanda, Marcelo Alcantara
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [27] Regulatory news: Avalglucosidase alfa-ngpt (Nexviazyme) for late-onset Pompe disease-FDA approval summary
    Punnoose, Ann R.
    Jeng, Linda J. B.
    Maynard, Janet W.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2022, 45 (06) : 1015 - 1017
  • [28] Polymorphism in exercise genes and respiratory function in late-onset Pompe disease
    Ravaglia, Sabrina
    Malovini, Alberto
    Cirio, Serena
    Danesino, Cesare
    De Filippi, Paola
    Moggio, Maurizio
    Mongini, Tiziana
    Maggi, Lorenzo
    Servidei, Serena
    Vianello, Andrea
    Toscano, Antonio
    Tonin, Paola
    Maioli, Maria Antonietta
    Parini, Rossella
    Filosto, Massimiliano
    Crescimanno, Grazia
    Arceri, Sebastiano
    Piran, Manuela
    Carlucci, Annalisa
    JOURNAL OF APPLIED PHYSIOLOGY, 2021, 131 (06) : 1762 - 1771
  • [29] Course of disability and respiratory function in untreated late-onset Pompe disease
    Hagemans, MLC
    Hop, WJC
    Van Doorn, PA
    Reuser, AJJ
    van der Ploeg, AT
    NEUROLOGY, 2006, 66 (04) : 581 - 583
  • [30] Mobility, usual activities and EQ-5D visual analogue score improvement with avalglucosidase alfa in Late-onset Pompe disease during the COMET trial
    Pollissard, L.
    DasMahapatra, P.
    Baranowski, E.
    Haack, K. An
    Zhou, T.
    Thibault, N.
    Msihid, J.
    Hamed, A.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S111 - S111
12345